317 related articles for article (PubMed ID: 30007793)
21. The level of 24-Hydroxycholesteryl Esters is an Early Marker of Alzheimer's Disease.
Benussi L; Ghidoni R; Dal Piaz F; Binetti G; Di Iorio G; Abrescia P
J Alzheimers Dis; 2017; 56(2):825-833. PubMed ID: 27983556
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
[TBL] [Abstract][Full Text] [Related]
23. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
[TBL] [Abstract][Full Text] [Related]
24. Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.
Chang CH; Lin CH; Liu CY; Huang CS; Chen SJ; Lin WC; Yang HT; Lane HY
J Psychopharmacol; 2021 Mar; 35(3):265-272. PubMed ID: 33586518
[TBL] [Abstract][Full Text] [Related]
25. Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer's Disease from Controls and Predict Progression from Mild Cognitive Impairment.
Llano DA; Devanarayan V;
J Alzheimers Dis; 2021; 80(1):311-319. PubMed ID: 33523012
[TBL] [Abstract][Full Text] [Related]
26. Optimisation of saliva volumes for lipidomic analysis by nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry.
Lee GB; Caner A; Moon MH
Anal Chim Acta; 2022 Feb; 1193():339318. PubMed ID: 35058012
[TBL] [Abstract][Full Text] [Related]
27. Identification of Plasma Proteins as Biomarkers for Mild Cognitive Impairment and Alzheimer's Disease Using Liquid Chromatography-Tandem Mass Spectrometry.
Inoue M; Suzuki H; Meno K; Liu S; Korenaga T; Uchida K
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685872
[TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease.
Byeon SK; Madugundu AK; Jain AP; Bhat FA; Jung JH; Renuse S; Darrow J; Bakker A; Albert M; Moghekar A; Pandey A
Mol Omics; 2021 Jun; 17(3):454-463. PubMed ID: 34125126
[TBL] [Abstract][Full Text] [Related]
29. Lipidomic Network of Mild Cognitive Impairment from the Mayo Clinic Study of Aging.
Wang X; Bui H; Vemuri P; Graff-Radford J; Jack CR; Petersen RC; Mielke MM
J Alzheimers Dis; 2021; 81(2):533-543. PubMed ID: 33814434
[TBL] [Abstract][Full Text] [Related]
30. Interrelationship between Mini-Mental State Examination scores and biochemical parameters in patients with mild cognitive impairment and Alzheimer's disease.
Vasantharekha R; Priyanka HP; Swarnalingam T; Srinivasan AV; ThyagaRajan S
Geriatr Gerontol Int; 2017 Oct; 17(10):1737-1745. PubMed ID: 27921357
[TBL] [Abstract][Full Text] [Related]
31. Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts.
Muenchhoff J; Poljak A; Song F; Raftery M; Brodaty H; Duncan M; McEvoy M; Attia J; Schofield PW; Sachdev PS
J Alzheimers Dis; 2015; 43(4):1355-73. PubMed ID: 25159666
[TBL] [Abstract][Full Text] [Related]
32. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
[TBL] [Abstract][Full Text] [Related]
33. Plasma metabolic profiling of mild cognitive impairment and Alzheimer's disease using liquid chromatography/mass spectrometry.
Liu Y; Li N; Zhou L; Li Q; Li W
Cent Nerv Syst Agents Med Chem; 2014; 14(2):113-20. PubMed ID: 25515716
[TBL] [Abstract][Full Text] [Related]
34. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
[TBL] [Abstract][Full Text] [Related]
35. Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's Disease.
Bergland AK; Proitsi P; Kirsebom BE; Soennesyn H; Hye A; Larsen AI; Xu J; Legido-Quigley C; Rajendran L; Fladby T; Aarsland D
J Alzheimers Dis; 2020; 77(3):1117-1127. PubMed ID: 32804144
[TBL] [Abstract][Full Text] [Related]
36. Plasma Homocysteine and Serum Folate and Vitamin B
Ma F; Wu T; Zhao J; Ji L; Song A; Zhang M; Huang G
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28698453
[TBL] [Abstract][Full Text] [Related]
37. A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease.
Olazarán J; Gil-de-Gómez L; Rodríguez-Martín A; Valentí-Soler M; Frades-Payo B; Marín-Muñoz J; Antúnez C; Frank-García A; Acedo-Jiménez C; Morlán-Gracia L; Petidier-Torregrossa R; Guisasola MC; Bermejo-Pareja F; Sánchez-Ferro Á; Pérez-Martínez DA; Manzano-Palomo S; Farquhar R; Rábano A; Calero M
J Alzheimers Dis; 2015; 45(4):1157-73. PubMed ID: 25649659
[TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
[TBL] [Abstract][Full Text] [Related]
39. Lipid alterations in the skeletal muscle tissues of mice after weight regain by feeding a high-fat diet using nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry.
Eum JY; Lee GB; Yi SS; Kim IY; Seong JK; Moon MH
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1141():122022. PubMed ID: 32062368
[TBL] [Abstract][Full Text] [Related]
40. Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment.
Wang G; Zhou Y; Huang FJ; Tang HD; Xu XH; Liu JJ; Wang Y; Deng YL; Ren RJ; Xu W; Ma JF; Zhang YN; Zhao AH; Chen SD; Jia W
J Proteome Res; 2014 May; 13(5):2649-58. PubMed ID: 24694177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
